Targeted molecular therapy of malignant gliomas

2005 ◽  
Vol 5 (3) ◽  
pp. 186-197 ◽  
Author(s):  
Santosh Kesari ◽  
Naren Ramakrishna ◽  
Claire Sauvageot ◽  
Charles D. Stiles ◽  
Patrick Y. Wen
Keyword(s):  
Malignant Gliomas ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy

Targeted molecular therapy of malignant gliomas

2006 ◽  
Vol 8 (1) ◽  
pp. 58-70 ◽  
Author(s):  
Santosh Kesari ◽  
Naren Ramakrishna ◽  
Claire Sauvageot ◽  
Charles D. Stiles ◽  
Patrick Y. Wen
Keyword(s):  
Malignant Gliomas ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy

scholarly journals Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

2018 ◽  
Vol Volume 11 ◽  
pp. 1997-2005 ◽  
Author(s):  
Cheng Peng ◽  
Liangyou Gu ◽  
Lei Wang ◽  
Qingbo Huang ◽  
Baojun Wang ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy

Targeted Molecular Therapy in Palliative Cancer Management

2020 ◽  
Vol 5 (1) ◽  
Author(s):  
Staats H ◽  
Cassidy C ◽  
Kelso J ◽  
Mack S ◽  
Morand S ◽  
...  
Keyword(s):  
Molecular Therapy ◽  
Targeted Molecular Therapy ◽  
Cancer Management

scholarly journals Current Concepts in Multi-Modality Imaging of Solid Tumor Angiogenesis

Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3239
Author(s):  
Moataz A. Soliman ◽  
Jeffrey Guccione ◽  
Anna M. Reiter ◽  
Ahmed W. Moawad ◽  
Ashley Etchison ◽  
...  
Keyword(s):  
Tumor Angiogenesis ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy ◽  
Imaging Evaluation ◽  
Non Invasive ◽  
Ideal Tool ◽  
Assess Treatment Response ◽  
Morphological Assessment ◽  
Therapeutic Responses ◽  
The Ideal

There have been rapid advancements in cancer treatment in recent years, including targeted molecular therapy and the emergence of anti-angiogenic agents, which necessitate the need to quickly and accurately assess treatment response. The ideal tool is robust and non-invasive so that the treatment can be rapidly adjusted or discontinued based on efficacy. Since targeted therapies primarily affect tumor angiogenesis, morphological assessment based on tumor size alone may be insufficient, and other imaging modalities and features may be more helpful in assessing response. This review aims to discuss the biological principles of tumor angiogenesis and the multi-modality imaging evaluation of anti-angiogenic therapeutic responses.

Targeted molecular therapy for cancer: The application of STI571 to gastrointestinal stromal tumor

2003 ◽  
Vol 40 (3) ◽  
pp. 144-193 ◽  
Author(s):  
Ronald P. DeMatteo ◽  
Robert G. Maki ◽  
Cristina Antonescu ◽  
Murray F. Brennan
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Stromal Tumor ◽  
Molecular Therapy ◽  
Targeted Molecular Therapy
Sign in / Sign up

Export Citation Format

Share Document